EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Late‐life emergence of neuropsychiatric symptoms and risk of cognitive impairment in cognitively unimpaired individuals

Therese H Kim iD, Elizabeth Head, Craig E L Stark, Lorena Sordo, Katharine A Kirby, Maria G Corona, Michelle McDonnell, Joshua D Grill, David L Sultzer iD

Alzheimer's & Dementia · 2025-08 · 21 (8)

DOI: 10.1002/alz.70619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 25.08.2025. Verfasst von Therese H Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, California, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Alzheimer Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Roche Diagnostics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Neuropsychiatric symptoms (NPS) often precede cognitive impairment. We investigated the longitudinal relationship between emergent, significant NPS and cognitive decline in cognitively unimpaired older adults. We also assessed the combined effect of NPS and Alzheimer's disease (AD) biomarkers on subsequent cognitive impairment. METHODS We included 190 cognitively unimpaired participants without NPS at baseline and tracked the emergence of significant NPS and conversion to mild cognitive impairment (MCI). RESULTS The average follow‐up was 8.1 years, with a maximum of 19 years. Participants with emergent, significant NPS had a 3.92‐fold higher risk of cognitive impairment than those without (95% confidence interval 1.51–10.17, P = 0.005). Individuals with NPS and AD biomarkers showed a markedly higher conversion rate to MCI than those with neither risk factor. DISCUSSION Our findings emphasize the role of emergent, significant NPS as early clinical indicators of cognitive impairment and suggest the potential benefit of incorporating clinical symptoms and neurobiological markers to better predict cognitive course. Highlights We investigated the association between emergent neuropsychiatric symptoms (NPS) and conversion to mild cognitive impairment (MCI). One hundred ninety cognitively unimpaired individuals were followed for an average of 8.1 years. Emergent NPS increased the risk of conversion to MCI > 3‐fold. After emergent NPS, cognitive test performance declined. The co‐occurrence of NPS and high cerebrospinal fluid phosphorylated tau181 amplified the risk of MCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionAlzheimer DiseaseHumansMaleFemaleAgedNeuropsychological TestsBiomarkersDisease ProgressionLongitudinal StudiesRisk FactorsAged, 80 and overtau Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseGeriatric Depression ScaleMild Behavioral Impairment ChecklistNeuropsychiatric Inventorycerebrospinal fluid biomarkerslongitudinal cohort studymild behavioral impairmentmild cognitive impairmentphosphorylated tau181

Substanzen

Biomarkerstau Proteins

Autor:innen und Institutionen

  • Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, California, USA.
  • Department of Pathology & Laboratory Medicine, School of Medicine, University of California, Irvine, Irvine, California, USA.
  • Department of Neurobiology and Behavior, School of Biological Sciences, University of California, Irvine, Irvine, California, USA.
  • Center for Statistical Consulting, Department of Statistics, University of California, Irvine, Irvine, California, USA.
  • Department of Psychiatry and Human Behavior, School of Medicine, University of California, Irvine, Irvine, California, USA.
  • Institute for Clinical and Translational Science, University of California, Irvine, Irvine, California, USA.

ORCID-Profile: Therese H Kim, David L Sultzer

Förderung

  • NIA NIH HHS
  • NIH HHS
  • Roche Diagnostics
  • National Institute on Aging
  • National Institutes of Health

Zitieren

APA

Kim, T. H., Head, E., Stark, C. E. L., Sordo, L., Kirby, K. A., Corona, M. G., McDonnell, M., Grill, J. D., & Sultzer, D. L. (2025). Late‐life emergence of neuropsychiatric symptoms and risk of cognitive impairment in cognitively unimpaired individuals. Alzheimer's & Dementia, 21(8). https://doi.org/10.1002/alz.70619

Vancouver

Kim TH, Head E, Stark CEL, Sordo L, Kirby KA, Corona MG, et al. Late‐life emergence of neuropsychiatric symptoms and risk of cognitive impairment in cognitively unimpaired individuals. Alzheimer's & Dementia. 2025;21(8). doi:10.1002/alz.70619

BibTeX
@article{Kim2025,
  author = {Kim, Therese H and Head, Elizabeth and Stark, Craig E L and Sordo, Lorena and Kirby, Katharine A and Corona, Maria G and McDonnell, Michelle and Grill, Joshua D and Sultzer, David L},
  title = {Late‐life emergence of neuropsychiatric symptoms and risk of cognitive impairment in cognitively unimpaired individuals},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {8},
  doi = {10.1002/alz.70619}
}
Kostenlos starten →